This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is It Worth Investing in Celestica (CLS) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Celestica (CLS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Can InterDigital Garner Customer Interests With Innovative Solutions?
by Zacks Equity Research
IDCC is set to showcase next-generation solutions at Mobile World Congress 2025.
MSI Cloud Solutions Get Highest FedRAMP Authorization: Stock to Gain?
by Zacks Equity Research
FedRAMP High Authorization will strengthen Motorola's collaboration with U.S. Government agencies and improve its commercial prospects.
Buy 5 Non-U.S. Tech Stocks Flying High on Strong Estimate Revisions
by Nalak Das
Five high-flying non-US. tech stocks have strong revenue and earnings growth potential for 2025. These are: CLS, TEAM, SPOT, SRAD, LOGI.
AMAT Q1 Earnings Beat: Will a Weak Guidance Drag the Stock Down?
by Zacks Equity Research
Applied Materials' first-quarter fiscal 2025 results reflect weakness in the Chinese market, Display and Adjacent and Corporate and Other segments.
PANW Q2 Earnings Beat: Will a Strong Guidance Lift the Stock?
by Zacks Equity Research
Palo Alto's second-quarter fiscal 2025 results reflect strength in the Subscription & Support segment backed by a modest increase in its Product revenues.
Is iShares International Small-Cap Equity Factor ETF (ISCF) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for ISCF
Tyler Q4 Earnings Beat: Will a Strong Guidance Lift the Stock?
by Zacks Equity Research
TYL's fourth-quarter 2024 revenues reflect the benefits of a rise in subscription revenues, driven by new software contracts.
Zacks.com featured highlights include Brinker International, Business First Bancshares, AZEK, Celestica and Boston Scientific
by Zacks Equity Research
Brinker International, Business First Bancshares, AZEK, Celestica and Boston Scientific have been highlighted in this Screen of The Week article.
CLS More Than Doubles in 6 Months Compared With Industry: Time to Buy?
by Supriyo Bose
CLS is well poised for sustained growth backed by robust infrastructure investments, solid technology know-how and wide industry experience.
5 Top-Ranked Efficient Stocks to Buy for Solid Gains Amid Volatility
by Santanu Roy
Invest in stocks of EAT, BFST, AZEK, CLS and BSX to tap their high efficiency levels.
Building a Position With 4 Top Relative Price Strength Stocks
by Nilanjan Choudhury
ENS, PCRX, CLS and ENVA are four stocks with explosive relative price strength.
European Shares Find a Surprise Bid: Global Week Ahead
by John Blank
Europe Inc. is ticking all the boxes: cheap valuations, earnings growth and momentum. Investors are pouring in.
Cloudflare Q4 Earnings & Revenues Beat: Will the Stock Move Upward?
by Zacks Equity Research
NET's fourth-quarter 2024 results reflect sustained momentum in the onboarding of large new enterprises and remarkable progress in the public sector.
MACOM Q1 Earnings Beat: Will Strong Outlook Lift MTSI Stock?
by Zacks Equity Research
MTSI's first-quarter fiscal 2025 results benefit from strong traction in products across telecom, data center, industrial and defense end markets.
VSH Q4 Earnings Miss: Will Weak Results Drag the Stock Down?
by Zacks Equity Research
Vishay Intertechnology's Q4 results reflect softness across MOSFET, Diodes, Optoelectronics, Resistors and Inductors segments.
AMETEK Q4 Earnings Beat: Will Q1 Outlook Drag the Stock Down?
by Zacks Equity Research
AME's fourth-quarter results reflect the headwinds of shipment delays as customers remain cautious in the year-end period.
Is Kanzhun (BZ) Stock Outpacing Its Computer and Technology Peers This Year?
by Zacks Equity Research
Here is how KANZHUN LIMITED Sponsored ADR (BZ) and Celestica (CLS) have performed compared to their sector so far this year.
JKHY Q2 Earnings Beat: Will 2025 Outlook Drag the Stock Down?
by Zacks Equity Research
Jack Henry & Associates' second-quarter fiscal 2025 results reflect modest growth across its Core, Payments, Complementary and Corporate & Other segments.
Is Celestica (CLS) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Celestica (CLS) could produce exceptional returns because of its solid growth attributes.
Can Celestica (CLS) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Celestica (CLS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Is Celestica (CLS) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Celestica (CLS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Best Momentum Stock to Buy for February 4th
by Zacks Equity Research
CLS, SKYW and FLEX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 4, 2025.
Is Schwab Fundamental International Small Company Index ETF (FNDC) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FNDC
Celestica Q4 Earnings In-Line With Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Solid growth in key end markets led CLS to report relatively modest fourth-quarter results.